Day: December 23, 2021

P2 Gold Closes Financings

P2 Gold Closes Financings

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) — P2 Gold Inc. (“P2” or the “Company”) (TSX-V:PGLD) reports that it has closed the non-brokered private placement of flow-through units (the “FT Offering”), premium flow-through units (the “PFT Offering”) and non-flow-through units (the “NFT Offering”) (collectively, the FT Offering, PFT Offering and NFT Offering are the “Private Placement”) for gross proceeds of approximately $5.68 million. In closing the Private Placement, the Company issued 3,959,933 flow-through-units (the “FT Units”) of the Company for gross proceeds of approximately $3.05 million, 1,458,616 premium flow-through units (the “PFT Units”) of the Company for gross proceeds of approximately $1.23 million...

Continue reading

Search Minerals Announces Closing of First Tranche of Private Placement for Proceeds of $5.3 Million

Search Minerals Announces Closing of First Tranche of Private Placement for Proceeds of $5.3 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY | OTCQB: SHCMF) (“Search” or the “Company”), is pleased to announce that the Company has closed the first tranche of its previously announced non-brokered private placement offering of 18,540,000 flow-through common shares of the Company (the “FT Shares“) at a price of $0.25 per FT Share (the “FT Offering”) and 3,711,113 units (the “Units”) at a price of $0.18 per Unit (the “Unit Offering”, together with the FT Offering, the “Private Placement”) for aggregate gross proceeds of $5,303,000. Each Unit consists of one common share (each, a “Share”) and one common share purchase warrant (a “Warrant“) in the capital of...

Continue reading

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

TOKYO, Japan and CAMBRIDGE, United Kingdom, Dec. 23, 2021 (GLOBE NEWSWIRE) — Sosei Group Corporation (“Sosei Heptares”; TSE: 4565) today announces that in connection with the Collaboration and License Agreement (“License Agreement”) with Neurocrine Biosciences, Inc. (“Neurocrine Biosciences”) announced 22 November 2021, the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) expired on 22 December 2021. As such, the License Agreement became effective on 22 December 2021. With completion of the applicable waiting period under the HSR Act, under the terms of the License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares an upfront payment of US$100 million, with the amount to be recognized as revenue in the fourth quarter of the financial year ending December 31, 2021. About...

Continue reading

Corvus Gold Provides Supplemental Disclosure for Proposed Plan of Arrangement

Corvus Gold Provides Supplemental Disclosure for Proposed Plan of Arrangement

VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, NASDAQ: KOR) announced today that it has filed with the Securities and Exchange Commission (the “SEC”) and SEDAR a Current Report on Form 8-K (the “Current Report”) containing certain additional information to supplement the management information circular dated November 25, 2021 (the “Circular”) for the special meeting of Corvus shareholders and optionholders to be held on January 6, 2022 related to the previously announced plan of arrangement (the “Arrangement”) between Corvus, 1323606 B.C. Unlimited Liability Company (the “Purchaser”), and AngloGold Ashanti Holdings plc. Pursuant to the Arrangement, the Purchaser will, among other things, acquire the remaining 80.5% of the outstanding common shares of Corvus,...

Continue reading

Stone Gold Inc. Announces Closing of $431,199.88 in First Tranche of Non-Brokered Private Placement

Stone Gold Inc. Announces Closing of $431,199.88 in First Tranche of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2021 (GLOBE NEWSWIRE) — Stone Gold Inc. (TSX-V: STG) (“Stone Gold” or the “Company“) is pleased to announce that, in connection with its previously announced non-brokered private placement on December 14, 2021 (the “Offering”), the Company has completed the first tranche (the “First Tranche”), of the Offering. The Offering is comprised of the sale of a combination of flow-through units of the Company (“FT Units”) at a price of $0.12 per FT Unit and hard-dollar units of the Company (“HD Units”) at a price $0.10 per HD Unit (the “Offering”). The First Tranche consisted of the sale of 2,384,999 FT Units and 1,450,000 HD Units for aggregate gross proceeds of $431,199.88. Each FT Unit is comprised...

Continue reading

IBC Advanced Alloys Reports Voting Results from the Election of Directors at its 2021 Annual General Meeting

IBC Advanced Alloys Reports Voting Results from the Election of Directors at its 2021 Annual General Meeting

FRANKLIN, Ind., Dec. 23, 2021 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) announces the details of the voting results from its 2021 Annual General Meeting (the “Meeting”), held on December 23, 2021, in Denver, CO. At the Meeting, the Shareholders set the number of directors at four and re-elected to the board of directors by ordinary resolution, Mark A. Smith, Simon Anderson, Geoff Hampson and Mike Jarvis to serve in office until the next annual general meeting of Shareholders or until their successors are duly elected or appointed. In addition, the Shareholders voted in favor of the appointment of Crowe MacKay LLP as auditors of the Company. By resolution passed via ballot, the Shareholders also voted to re-approve the 2018 Stock Option Plan. The results of the ballot were as...

Continue reading

Credicorp LTD: Decisions made by Credicorp’s Board December 2021

Credicorp LTD: Decisions made by Credicorp’s Board December 2021

Lima, Dec. 23, 2021 (GLOBE NEWSWIRE) — Lima, PERU, December 23th, 2021 – Credicorp Ltd. announces to its shareholders and the market the decisions made by the Board of Directors in the session held on December 23th, 2021. New members of the Risk Committee and the Remuneration and Nominations Committee The Board designated Patricia Lizarraga Guthertz and Maria Teresa Aranzábal Harreguy as new members of the Risk Committee and the Remuneration and Nominations Committee respectively. These designations are aligned with Credicorp´s ESG ambition to champion diversity, inclusion and gender equality and are in keeping with a recent Corporate Governance guideline that recommends including at least one female Board member on each Board Committee. Ms. Lizarraga has been a director of Banco de Credito del Peru and of Credicorp Ltd since...

Continue reading

Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors

Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors

LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Inese Lowenstein to its Board of Directors. “We are very excited to welcome Inese, an experienced Life Science business leader in the STEM (science, technology, engineering and mathematics) field to our board of directors,” said President and Chief Executive Officer, Robert Spignesi. “She has held leadership positions at Danaher Corporation (“Danaher”), SCIEX, Merck KGaA, and EMD Millipore and has a track record of delivering strong results by building highly performing teams and driving commercial execution, customer-focused...

Continue reading

Escalade Appoints Walter P. Glazer, Jr. as Chief Executive Officer and President

Escalade Appoints Walter P. Glazer, Jr. as Chief Executive Officer and President

Evansville, Ind., Dec. 23, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Escalade, Incorporated, is pleased to announce the appointment of Walter P. Glazer, Jr. as full-time Chief Executive Officer and President effective January 1, 2022. Mr. Glazer has been serving as interim Chief Executive Officer and President. “The Escalade board has appreciated Walt’s willingness to step in and serve as interim CEO since February of this year,” said Ned Williams, Escalade’s Lead Independent Director, “and we are pleased to have his leadership as we begin our 100th year in business!”   “I have been a shareholder since 1991 and board member for the past 6 years,” commented Walt Glazer. “Stepping into the interim role this year gave me a great appreciation for the complete Escalade organization. I’m energized and excited...

Continue reading

Vaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

Vaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the third quarter ended September 30, 2021. “The completion of our recent initial public offering is an important milestone in Vaxxinity’s mission to democratize health,” said Mei Mei Hu, CEO of Vaxxinity. “With the goal to disrupt the existing antibody therapy paradigm and improve the quality of chronic disease treatments while increasing their convenience and meaningfully lowering their cost, we believe we have the opportunity to profoundly impact the lives of countless patients across the globe. The funds raised in our recent IPO are critical to advancing our potentially transformative vaccine candidates toward approval.” Recent Pipeline...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.